Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evolent Health

8.65
+0.16001.88%
Volume:1.71M
Turnover:14.78M
Market Cap:1.00B
PE:-7.08
High:8.84
Open:8.44
Low:8.36
Close:8.49
Loading ...

Evolent Health Amends Credit Agreement for Flexibility

TIPRANKS
·
Just now

BRIEF-Evolent Health Outlook Q2 Adjusted EBITDA USD 33-40 Million

Reuters
·
32 mins ago

Evolent Health Reiterates Q2 and Full Year Adjusted EBITDA Guidance Amid Lower-than-Expected Oncology Costs

Reuters
·
32 mins ago

Evolent Reiterates Q2 and Full Year Guidance for Adjusted Ebitda

THOMSON REUTERS
·
33 mins ago

Evolent Health Outlook FY Adjusted Ebitda USD 135-165 Million

THOMSON REUTERS
·
33 mins ago

Evolent Health Inc. Files Initial Statement of Beneficial Ownership for Director Shawn Guertin

Reuters
·
09 Jun

Evolent Health Inc. Conducted Annual Meeting of Stockholders

Reuters
·
06 Jun

BRIEF-Evolent Health - Reaffirms 2025 Revenue Guidance Of $2.06 Bln To $2.11 Bln - SEC Filing

Reuters
·
03 Jun

Evolent Health Inc - Reaffirms Q2 2025 Revenue Guidance of $440 Mln to $470 Mln - SEC Filing

THOMSON REUTERS
·
03 Jun

Evolent Health Inc Q2 REV View $459.4 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
03 Jun

Evolent Health Inc - Reaffirms 2025 Revenue Guidance of $2.06 Bln to $2.11 Bln - SEC Filing

THOMSON REUTERS
·
03 Jun

Evolent Health Price Target Maintained With a $15.00/Share by Needham

Dow Jones
·
13 May

Evolent Health Is Maintained at Buy by UBS

Dow Jones
·
10 May

UBS Adjusts Price Target on Evolent Health to $15 From $14, Maintains Buy Rating

MT Newswires Live
·
09 May

Stock Track | Evolent Health Soars 7.19% Pre-Market on Positive Analyst Ratings and Price Target Hike

Stock Track
·
09 May

Evolent Health (EVH) Receives a Buy from TD Cowen

TIPRANKS
·
09 May

Evolent Health price target raised to $15 from $14 at UBS

TIPRANKS
·
09 May

Evolent Health Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Evolent Health Q1 Adj. EPS $0.06 Misses $0.10 Estimate, Sales $483.65M Beat $460.31M Estimate

Benzinga
·
09 May

BRIEF-Evolent Health Q1 Revenue USD 483.649 Million Vs. IBES Estimate USD 460.3 Million

Reuters
·
09 May